{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Healthy Enterprise","title":"Biotech for the Planet: An AI-Driven Approach to Sustainable Materials with Yuliana Mihaylova","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/72a7a042\"></iframe>","width":"100%","height":180,"duration":2697,"description":"In this episode of The Healthy Enterprise as we dive into the world of sustainable innovation with Yuliana Mihaylova, a biotech executive and co-founder of OliveBio. Discover how Yuliana's journey from a PhD in genetics to an entrepreneur is paving the way for eco-friendly alternatives to petrochemical plastics. Learn about the challenges and triumphs of creating scalable bioplastics and the role of AI in revolutionizing production processes.Chapters:00:14 Introduction to OliveBio and Yuliana's Background02:01 The Motivation Behind OliveBio: Tackling Plastic Pollution06:15 Understanding PHAs: A Sustainable Bioplastic Solution11:59 OliveBio's Innovative Production Process for PHAs15:57 Applications and Future of Bioplastics18:21 Yuliana's Entrepreneurial Journey and Challenges22:36 Leveraging AI and Automation in Biotech33:13 Marketing and Growth Strategy for OliveBio36:49 Vision for OliveBio's Future Impact39:43 Key Learnings and Advice for Aspiring InnovatorsGuest Information:Guest's Name: Yuliana MihaylovaGuest's Title/Position: CEO & Co-FounderGuest's Linkedin: https://www.linkedin.com/in/yulianamihaylova/Company / Affiliation: OliveBio https://olivebio.com/Guest's Bio: Yuliana Mihaylova is a seasoned biotech executive and the team’s mission enforcer. After completing her Genetics PhD and post-doctoral research at the universities of Nottingham and Oxford, respectively, she worked in biotech and pharma management consulting, where she helped companies develop their asset commercialization and market access strategies. From 2019 to 2024, Yuliana was part of the executive team at Basepaws, a pet genetics company, acquired by the animal pharma startup Zoetis in 2022. As Basepaws’ Head of R&D, she led the development and refinement of new technologies and scientific products and was a key stakeholder in the translation of scientific discovery into business strategy.Yuliana believes strongly in the power of cross-disciplinary collaboration and innovative thinking...","thumbnail_url":"https://img.transistorcdn.com/WKku9MQ84q-0q9Awqd5xdS4eoTolo1ocic6_1x8xlF0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMjI4/MDliNWYyM2MxYWFi/NTkwZmIwNzJkYjk2/YjliMy5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}